Clinical and molecular characterization of five new individuals with WAC‐related intellectual disability: Evidence of pathogenicity for a novel splicing variant
- 12 January 2022
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (5) , 1396-1406
Abstract
WAC‐related intellectual disability (ID) is a rare genetic condition characterized by a spectrum of neurodevelopmental disorders of varying severity, including global developmental delay (GDD), ID, and autism spectrum disorder. Here, we describe five affected individuals, age range 9–20 years, and provide proof of pathogenicity of a novel splicing variant. All individuals presented with GDD, some degree of ID, and variable dysmorphism. Except for feeding difficulties, all patients were healthy without major congenital malformations or medical comorbidities. All individuals were heterozygous for de novo, previously unreported, loss of function variants in WAC. Three unrelated patients from different ethnic backgrounds shared the intronic variant c.381+4_381+7delAGTA, which was predicted to alter splicing and was initially classified as a variant of uncertain significance. Reverse transcription‐polymerase chain reaction analysis from one patient's cells confirmed aberrant splicing of the WAC transcript resulting in premature termination and a truncated protein p.(Gly92Alafs*2). These functional studies and the identification of several nonrelated individuals provide sufficient evidence to classify this variant as pathogenic. The clinical description of these five individuals and the three novel variants expand the genotypic and phenotypic spectrum of this ultrarare disease.Keywords
This publication has 19 references indexed in Scilit:
- De novo loss-of-function mutations in WAC cause a recognizable intellectual disability syndrome and learning deficits in DrosophilaEuropean Journal of Human Genetics, 2016
- WAC Regulates mTOR Activity by Acting as an Adaptor for the TTT and Pontin/Reptin ComplexesDevelopmental Cell, 2016
- WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndromeJournal of Medical Genetics, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- De Novo Mutations in Moderate or Severe Intellectual DisabilityPLOS Genetics, 2014
- Interstitial 10p11.23–p12.1 microdeletions associated with developmental delay, craniofacial abnormalities, and cryptorchidismAmerican Journal of Medical Genetics Part A, 2014
- The Histone H2B Monoubiquitination Regulatory Pathway Is Required for Differentiation of Multipotent Stem CellsMolecular Cell, 2012
- Deletion at chromosome 10p11.23-p12.1 defines characteristic phenotypes with marked midface retrusionJournal of Human Genetics, 2012
- Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11European Journal of Human Genetics, 2011
- WAC, a Functional Partner of RNF20/40, Regulates Histone H2B Ubiquitination and Gene TranscriptionMolecular Cell, 2011